Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies
This study is ongoing, but not recruiting participants.
Vanquish Oncology, Inc.
University of Illinois at Chicago
Information provided by (Responsible Party):
Oana Danciu, MD, University of Illinois at Chicago
First received: January 30, 2015
Last updated: May 17, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||March 2018 (Final data collection date for primary outcome measure)|